Literature DB >> 22632639

American trypanosomiasis (Chagas disease).

Anis Rassi1, Anis Rassi1, Joffre Marcondes de Rezende.   

Abstract

Chagas disease, also known as American trypanosomiasis, is a chronic infection caused by Trypanosoma cruzi, a protozoan parasite. It is transmitted to human beings mainly through the feces of infected triatomine bugs. The disease affects an estimated 8 to 10 million people in the Americas, putting them at risk of developing life-threatening cardiac and gastrointestinal complications. This article provides a brief update on the epidemiology, clinical manifestations, diagnosis, and treatment of Chagas disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632639     DOI: 10.1016/j.idc.2012.03.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  150 in total

Review 1.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

2.  Structures containing galectin-3 are recruited to the parasitophorous vacuole containing Trypanosoma cruzi in mouse peritoneal macrophages.

Authors:  Lissa Catherine Reignault; Emile Santos Barrias; Lia Carolina Soares Medeiros; Wanderley de Souza; Tecia Maria Ulisses de Carvalho
Journal:  Parasitol Res       Date:  2014-04-24       Impact factor: 2.289

3.  Peripheral nervous system manifestations of infectious diseases.

Authors:  Kate T Brizzi; Jennifer L Lyons
Journal:  Neurohospitalist       Date:  2014-10

4.  Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.

Authors:  Christoph Niederhauser; Jochen Gottschalk; Caroline Tinguely
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

5.  A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.

Authors:  Carylinda Serna; Joshua A Lara; Silas P Rodrigues; Alexandre F Marques; Igor C Almeida; Rosa A Maldonado
Journal:  Vaccine       Date:  2014-04-30       Impact factor: 3.641

Review 6.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Performance Assessment of a Trypanosoma cruzi Chimeric Antigen in Multiplex Liquid Microarray Assays.

Authors:  Fred Luciano Neves Santos; Paola Alejandra Fiorani Celedon; Nilson Ivo Tonin Zanchin; Amanda Leitolis; Sandra Crestani; Leonardo Foti; Wayner Vieira de Souza; Yara de Miranda Gomes; Marco Aurélio Krieger
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

8.  Chagas Disease Knowledge and Risk Behaviors of the Homeless Population in Houston, TX.

Authors:  Alexandra Ingber; Melissa N Garcia; Juan Leon; Kristy O Murray
Journal:  J Racial Ethn Health Disparities       Date:  2017-05-31

9.  Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.

Authors:  Fred Luciano Neves Santos; Wayner Vieira de Souza; Michelle da Silva Barros; Mineo Nakazawa; Marco Aurélio Krieger; Yara de Miranda Gomes
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

10.  Potential therapeutic use of herbal extracts in trypanosomiasis.

Authors:  Thaise L Teixeira; Samuel Cota Teixeira; Claudio Vieira da Silva; Maria A de Souza
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.